The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail marketed products, revenue forecasts, product pipeline and competitive structure.
